Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.

Gynecologic oncology - 1 Dec 2011

Bondurant Amy E, Huang Zhiqing, Whitaker Regina S, Simel Lauren R, Berchuck Andrew, Murphy Susan K

Abstract excerpt

OBJECTIVE: Detection of cell free tumor-specific DNA methylation has been proposed as a potentially useful noninvasive mechanism to detect malignancies, including ovarian cancer, and to monitor response to treatment. However, there are few easily implemented quantitative approaches available for DNA methylation analysis. Our objectives were to develop an absolute quantitative method for detection of DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Neoplasm Staging

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Real-Time Polymerase Chain Reaction

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 21955482
DOI: 10.1016/j.ygyno.2011.08.029

Genes

ACTB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.PMID 21955482Read ↗

Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian CarcinomaSemantic proximity Read ↗

RASSF1Apromoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNASemantic proximity Read ↗

A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNASemantic proximity Read ↗

Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: comparison with methylation-specific PCR technique and clinical significance.Semantic proximity Read ↗

Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.Semantic proximity Read ↗

A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus.Semantic proximity Read ↗

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.Semantic proximity Read ↗

Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry.Semantic proximity Read ↗

Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.Semantic proximity Read ↗

Ultrasensitive amplification-free quantification of a methyl CpG-rich cancer biomarker by single-molecule kinetic fingerprintingSemantic proximity Read ↗

Methylation Profile of BRCA1, RASSF1A and ER in Vietnamese Women with Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.